ACCELERON PHARMA INC. Revenue
ACCELERON PHARMA INC. reported Revenue of $3.23 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2018-05-08
- ACCELERON PHARMA INC. revenues for the quarter ending 2018-03-31 was $3.23M, a 12.77% decline year-over-year.
- ACCELERON PHARMA INC. revenues for the quarter ending 2017-12-31 was $3.71M, a 9.97% increase year-over-year.
- ACCELERON PHARMA INC. revenues for the quarter ending 2017-09-30 was $3.01M, a 0.30% increase year-over-year.
- ACCELERON PHARMA INC. revenues for the quarter ending 2017-06-30 was $3.06M, a 4.32% decline year-over-year.
- ACCELERON PHARMA INC. revenues for fiscal 2017 was $13.48M, a 51.46% decline from fiscal 2016.
- ACCELERON PHARMA INC. revenues for fiscal 2016 was $27.77M, a 53.46% increase from fiscal 2015.
- ACCELERON PHARMA INC. revenues for fiscal 2015 was $18.10M, a 23.68% increase from fiscal 2014.
- ACCELERON PHARMA INC. revenues for fiscal 2014 was $14.63M, a 74.43% decline from fiscal 2013.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2018-03-31 | $3.23M 10-Q · filed 2018-05-08 | $6.94M derived: sum of 2 quarters · filed 2018-05-08 | $9.95M derived: sum of 3 quarters · filed 2018-05-08 | $13.01M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-12-31 | $3.71M 10-K · filed 2018-02-27 | $6.72M derived: sum of 2 quarters · filed 2018-02-27 | $9.78M derived: sum of 3 quarters · filed 2018-02-27 | $13.48M 10-K · filed 2018-02-27 |
| 2017-09-30 | $3.01M 10-K · filed 2018-02-27 | $6.07M derived: sum of 2 quarters · filed 2018-02-27 | $9.78M 10-Q · filed 2017-11-07 | $13.14M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-06-30 | $3.06M 10-K · filed 2018-02-27 | $6.76M 10-Q · filed 2017-08-03 | $10.13M derived: sum of 3 quarters · filed 2018-05-08 | $13.14M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-03-31 | $3.71M 10-Q · filed 2018-05-08 | $7.07M derived: sum of 2 quarters · filed 2018-05-08 | $10.08M derived: sum of 3 quarters · filed 2018-05-08 | $13.27M derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | $3.37M 10-K · filed 2018-02-27 | $6.37M derived: sum of 2 quarters · filed 2018-02-27 | $9.57M derived: sum of 3 quarters · filed 2018-02-27 | $27.77M 10-K · filed 2018-02-27 |
| 2016-09-30 | $3.00M 10-K · filed 2018-02-27 | $6.20M derived: sum of 2 quarters · filed 2018-02-27 | $24.40M 10-Q · filed 2017-11-07 | $28.20M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $3.19M 10-K · filed 2018-02-27 | $21.40M 10-Q · filed 2017-08-03 | $25.20M derived: sum of 3 quarters · filed 2018-02-27 | $29.36M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $18.20M 10-K · filed 2018-02-27 | $22.00M derived: sum of 2 quarters · filed 2018-02-27 | $26.16M derived: sum of 3 quarters · filed 2018-02-27 | $31.88M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $3.80M 10-K · filed 2017-03-01 | $7.96M derived: sum of 2 quarters · filed 2017-03-01 | $13.68M derived: sum of 3 quarters · filed 2017-03-01 | $18.10M 10-K · filed 2018-02-27 |
| 2015-09-30 | $4.16M 10-K · filed 2017-03-01 | $9.87M derived: sum of 2 quarters · filed 2017-03-01 | $14.29M 10-Q · filed 2016-11-03 | $18.03M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $5.72M 10-K · filed 2017-03-01 | $10.14M 10-Q · filed 2016-08-04 | $13.88M derived: sum of 3 quarters · filed 2017-03-01 | $17.38M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $4.42M 10-K · filed 2017-03-01 | $8.16M derived: sum of 2 quarters · filed 2017-03-01 | $11.67M derived: sum of 3 quarters · filed 2017-03-01 | $15.74M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $3.74M 10-K · filed 2016-02-25 | $7.25M derived: sum of 2 quarters · filed 2016-02-25 | $11.32M derived: sum of 3 quarters · filed 2016-02-25 | $14.63M 10-K · filed 2017-03-01 |
| 2014-09-30 | $3.51M 10-K · filed 2016-02-25 | $7.59M derived: sum of 2 quarters · filed 2016-02-25 | $10.89M 10-Q · filed 2015-11-04 | $22.41M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $4.08M 10-K · filed 2016-02-25 | $7.38M 10-Q · filed 2015-08-06 | $18.91M derived: sum of 3 quarters · filed 2016-02-25 | $23.18M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $3.31M 10-K · filed 2016-02-25 | $14.83M derived: sum of 2 quarters · filed 2016-02-25 | $19.10M derived: sum of 3 quarters · filed 2016-02-25 | $45.52M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $11.52M 10-K · filed 2015-03-02 | $15.79M derived: sum of 2 quarters · filed 2015-03-02 | $42.22M derived: sum of 3 quarters · filed 2015-03-02 | $57.23M 10-K · filed 2016-02-25 |
| 2013-09-30 | $4.27M 10-K · filed 2015-03-02 | $30.70M derived: sum of 2 quarters · filed 2015-03-02 | $45.71M 10-Q · filed 2014-11-07 | $49.69M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $26.43M 10-K · filed 2015-03-02 | $41.44M 10-Q · filed 2014-08-12 | $45.42M derived: sum of 3 quarters · filed 2015-03-02 | $49.33M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $15.01M 10-K · filed 2015-03-02 | $19.00M derived: sum of 2 quarters · filed 2015-03-02 | $22.90M derived: sum of 3 quarters · filed 2015-03-02 | $26.94M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $3.98M 10-K · filed 2014-03-17 | $7.89M derived: sum of 2 quarters · filed 2014-03-17 | $11.93M derived: sum of 3 quarters · filed 2014-03-17 | $15.25M 10-K · filed 2015-03-02 |
| 2012-09-30 | $3.90M 10-K · filed 2014-03-17 | $7.95M derived: sum of 2 quarters · filed 2014-03-17 | $11.27M 10-Q · filed 2013-11-14 | |
| 2012-06-30 | $4.04M 10-K · filed 2014-03-17 | $7.36M derived: sum of 2 quarters · filed 2014-03-17 | ||
| 2012-03-31 | $3.32M 10-K · filed 2014-03-17 | |||
| 2011-12-31 | $80.91M 10-K · filed 2014-03-17 |